CN105213402A - A kind of poultry compound enrofloxacin meloxicam soluble powder - Google Patents

A kind of poultry compound enrofloxacin meloxicam soluble powder Download PDF

Info

Publication number
CN105213402A
CN105213402A CN201510658306.0A CN201510658306A CN105213402A CN 105213402 A CN105213402 A CN 105213402A CN 201510658306 A CN201510658306 A CN 201510658306A CN 105213402 A CN105213402 A CN 105213402A
Authority
CN
China
Prior art keywords
meloxicam
grams
enrofloxacin
mixture
livestock
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510658306.0A
Other languages
Chinese (zh)
Other versions
CN105213402B (en
Inventor
胡涵
张义仁
魏迎军
李润乐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Luoyang Luoshen Pharmaceutical Co ltd
Original Assignee
Luoyang Veterinary Medicines Factory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luoyang Veterinary Medicines Factory filed Critical Luoyang Veterinary Medicines Factory
Priority to CN201510658306.0A priority Critical patent/CN105213402B/en
Publication of CN105213402A publication Critical patent/CN105213402A/en
Application granted granted Critical
Publication of CN105213402B publication Critical patent/CN105213402B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

一种畜禽复方恩诺沙星美洛昔康可溶性粉,由以下组分制备构成:恩诺沙星2.5-10克,美洛昔康0.05-1.0克,助溶剂2.5-10克,稳定剂0.5-4克,甜味剂1-2克,香味剂1-2克,辅料92-72克;制备方法为:将美洛昔康与助溶剂混合搅拌得到混合物A,混合物A加到恩诺沙星中得到混合物B,将稳定剂、甜味剂、香味剂混合得到混合物C,混合物C加到辅料中混合制得混合物D,混合物B与混合物D混合制得混合物E,混合物E过筛包装后封口制得成品;对家畜的适口性有显著改善,具有诱食作用和压制苦味的作用,可通过饮水或者内服给药,使用方便,使用效果好。A compound enrofloxacin-meroxicam soluble powder for livestock and poultry is prepared from the following components: 2.5-10 grams of enrofloxacin, 0.05-1.0 grams of meloxicam, 2.5-10 grams of solubilizer, 0.5-4 grams of stabilizer, 1-2 grams of sweetener, 1-2 grams of flavoring agent, and 92-72 grams of excipients. The preparation method is as follows: Meloxicam and solubilizer are mixed to obtain mixture A; mixture A is added to enrofloxacin to obtain mixture B; stabilizer, sweetener, and flavoring agent are mixed to obtain mixture C; mixture C is added to the excipients and mixed to obtain mixture D; mixture B and mixture D are mixed to obtain mixture E; mixture E is sieved, packaged, and sealed to obtain the finished product. It significantly improves palatability in livestock, has an appetite-stimulating effect and suppresses bitterness, and can be administered via drinking water or orally. It is convenient to use and has good efficacy.

Description

一种畜禽复方恩诺沙星美洛昔康可溶性粉A kind of livestock and poultry compound enrofloxacin meloxicam soluble powder

技术领域technical field

本发明涉及兽药技术领域的药物,尤其是一种畜禽复方恩诺沙星美洛昔康可溶性粉。The invention relates to medicines in the technical field of veterinary medicines, in particular to a soluble powder of livestock and poultry compound enrofloxacin and meloxicam.

背景技术Background technique

恩诺沙星属于氟喹诺酮类化学合成抑菌剂,为微黄色或淡黄色结晶性粉末,味苦,不溶于水,易溶于碱性溶液,为动物专用广谱杀菌药,本品为第三代喹诺酮类抗菌药物,能与细菌DNA回旋酶亚基A结合,从而抑制了酶的切割与连接功能,阻止了细菌DNA的复制,而呈现抗菌作用。口服吸收迅速和较完全,0.5--2小时血药度达高峰,血药浓度高且稳定,能广泛分布于组织中,除了中枢神经系统外,几乎所有的组织的药物浓度都高于血浆,这有利于全身感染和深部组织感染的治疗。本品通过肾和非肾方式进行消除,约15%--50%的药物原形通过尿排泄。其代谢产物为环丙沙星,仍有强大抗菌作用。本品对支原体有特效。对大肠杆菌、克雷伯氏菌、沙门氏菌、变形杆菌、绿脓杆菌、嗜血杆菌、多杀性巴氏杆菌、溶血性巴氏杆菌、金葡菌、链球菌等都有杀菌效用。但该药只有对因治疗作用,见效相对慢,此外其味极苦,在水中不溶解,口服给药对味觉发达的猪来说适口性很差,产生厌食现象,影响采食量,限制了该药的使用。Enrofloxacin belongs to fluoroquinolone chemically synthesized antibacterial agent, which is slightly yellow or light yellow crystalline powder, bitter in taste, insoluble in water, easily soluble in alkaline solution, and is a broad-spectrum antibacterial drug for animals. The third-generation quinolone antibacterial drugs can bind to subunit A of bacterial DNA gyrase, thereby inhibiting the cutting and joining functions of the enzyme, preventing the replication of bacterial DNA, and exhibiting antibacterial effects. Oral absorption is rapid and relatively complete, the blood drug concentration reaches the peak in 0.5--2 hours, the blood drug concentration is high and stable, and can be widely distributed in tissues. Except for the central nervous system, the drug concentration in almost all tissues is higher than that in plasma. This facilitates the treatment of systemic infections and deep tissue infections. This product is eliminated through renal and non-renal means, about 15% - 50% of the original drug is excreted through urine. Its metabolite is ciprofloxacin, which still has strong antibacterial effect. This product has special effects on mycoplasma. It has bactericidal effect on Escherichia coli, Klebsiella, Salmonella, Proteus, Pseudomonas aeruginosa, Haemophilus, Pasteurella multocida, Pasteurella hemolyticus, Staphylococcus aureus, Streptococcus, etc. But this medicine is only to because of therapeutic effect, takes effect relatively slowly, and its taste is extremely bitter in addition, and insoluble in water, and oral administration is very poor to the pig with developed sense of taste, produces anorexia phenomenon, influences feed intake, has limited use of this medicine.

鉴于上述原因,现研发出一种畜禽复方恩诺沙星美洛昔康可溶性粉。In view of the above reasons, a livestock and poultry compound enrofloxacin meloxicam soluble powder has been developed.

发明内容Contents of the invention

本发明的目的是为了克服现有技术中的不足,提供一种畜禽复方恩诺沙星美洛昔康可溶性粉,对家畜的适口性有显著改善,具有诱食作用和压制苦味的作用,可通过饮水或者内服(投服、拌料)给药,使用方便,使用效果好,The purpose of the present invention is to overcome the deficiencies in the prior art, to provide a kind of livestock and poultry compound enrofloxacin meloxicam soluble powder, which can significantly improve the palatability of livestock, has the effect of attracting food and suppressing bitterness, It can be administered through drinking water or oral administration (administration, mixing), which is convenient to use and has good effect.

本发明为了实现上述目的,采用如下技术方案:In order to achieve the above object, the present invention adopts the following technical solutions:

一种畜禽复方恩诺沙星美洛昔康可溶性粉,由以下组分制备构成:恩诺沙星2.5-10克,美洛昔康0.05-1.0克,助溶剂2.5-10克,稳定剂0.5-4克,甜味剂1-2克,香味剂1-2克,辅料92-72克。A livestock and poultry compound enrofloxacin-meloxicam soluble powder, which is prepared from the following components: 2.5-10 grams of enrofloxacin, 0.05-1.0 grams of meloxicam, 2.5-10 grams of co-solvent, stabilizer 0.5-4 grams, 1-2 grams of sweetener, 1-2 grams of flavoring agent, 92-72 grams of auxiliary materials.

美洛昔康与恩诺沙星重量比为0.2-1.0∶10,所述的美洛昔康除采用美洛昔康本身外,还可采用美洛昔康固体分散体或美洛昔康碱性盐。The weight ratio of meloxicam to enrofloxacin is 0.2-1.0:10, and the described meloxicam can also use meloxicam solid dispersion or meloxicam base in addition to meloxicam itself sexual salt.

所述的美洛昔康固体分散体是指美洛昔康用熔融共溶法制备的美洛昔康PEG6000固体分散体,所述的美洛昔康碱性盐为葡甲胺盐或钠盐或钾盐或铵盐。Described meloxicam solid dispersion refers to the meloxicam PEG6000 solid dispersion that meloxicam prepares by melting co-dissolution method, and described meloxicam basic salt is meglumine salt or sodium salt Or potassium or ammonium salt.

所述的助溶剂采用碳酸钠或碳酸钾。Described cosolvent adopts sodium carbonate or potassium carbonate.

所述的稳定剂是选自EDTA2钠、依地酸钙钠、三聚磷酸钠、N-(2-羟乙基)-乙二胺三乙酸钠、N-(2-羟乙基)-甘氨酸,其中一种或几种的组合。The stabilizer is selected from sodium EDTA2, calcium sodium edetate, sodium tripolyphosphate, N-(2-hydroxyethyl)-sodium ethylenediaminetriacetate, N-(2-hydroxyethyl)-glycine , one or a combination of several of them.

所述的甜味剂是选自,甜菊糖、山梨糖醇、甘露糖醇、麦芽糖醇、木糖醇糖精、甜蜜素、阿斯巴甜和安赛蜜,其中一种或几种的组合。The sweetener is selected from stevioside, sorbitol, mannitol, maltitol, xylitol saccharin, cyclamate, aspartame and acesulfame potassium, one or a combination thereof.

所述的香味剂是选自:乙基香兰素、天然香料提取物、乙基麦芽酚、乙酸异戊酯、丁酸乙酯,其中一种或几种的组合。The flavoring agent is selected from: ethyl vanillin, natural fragrance extract, ethyl maltol, isoamyl acetate, ethyl butyrate, one or a combination thereof.

所述的辅料是选自:葡萄糖、乳糖、蔗糖、水溶性淀粉、无水硫酸钠、碳酸氢钠,其中一种或几种的组合。The auxiliary material is selected from: glucose, lactose, sucrose, water-soluble starch, anhydrous sodium sulfate, sodium bicarbonate, one or more combinations thereof.

制备方法如下:第一步,将美洛昔康与助溶剂逐级递增混合搅拌均匀,得到混合物A,再把制得的混合物A加到恩诺沙星中,得到混合物B,备用;The preparation method is as follows: in the first step, meloxicam and the co-solvent are gradually mixed and stirred uniformly to obtain a mixture A, and then the prepared mixture A is added to enrofloxacin to obtain a mixture B, which is set aside;

第二步,将稳定剂、甜味剂、香味剂混合搅拌均匀得到混合物C,再把制得的混合物C加到辅料中搅拌混合均匀,制得混合物D,最后将制得的混合物B与混合物D在室温下搅拌均匀,制得混合物E,备用;In the second step, mix and stir the stabilizer, sweetener, and flavoring agent to obtain mixture C, then add the prepared mixture C to the auxiliary materials and stir and mix evenly to obtain mixture D, and finally mix the prepared mixture B with the mixture D is stirred evenly at room temperature to obtain mixture E, which is set aside;

第三步,将制得的混合物E直接过筛或先粉碎后再过筛,筛网采用60~80目筛,按50g~1000g分装于包装袋或包装瓶中,封口或压盖后制得成品。The third step is to directly sieve the prepared mixture E or first crush it and then sieve it. The sieve uses a 60-80 mesh sieve, and packs it into a packaging bag or a packaging bottle according to 50g-1000g, and seals or presses the cap. Get the finished product.

本发明的有益效果是:美洛昔康为非甾体抗炎药,具有镇痛、抗炎、解热作用,其机理可能与抑制前列腺素的合成有关。美洛昔康与恩诺沙星做成复方后合用,对细菌感染性疾病引起的发烧、疼痛及炎症有标本兼治的作用,本品增加了稳定剂后对恩诺沙星在不同水质中溶解和在胃中有较好的保护作用,克服了水中及胃内消化后的钙镁等金属离子与恩诺沙星结合影响吸收的问题。香味剂和甜味剂的添加起到诱食作用和压制苦味的作用,改善适口性。助溶剂的使用使恩诺沙星能够溶解于水,方便禽用和不食患畜饮水应用。The beneficial effects of the present invention are: meloxicam is a non-steroidal anti-inflammatory drug, which has analgesic, anti-inflammatory and antipyretic effects, and its mechanism may be related to inhibiting the synthesis of prostaglandins. Meloxicam and enrofloxacin are compounded and used together to treat fever, pain and inflammation caused by bacterial infectious diseases. And it has a better protective effect in the stomach, and overcomes the problem that the combination of metal ions such as calcium and magnesium in water and digested stomach with enrofloxacin affects the absorption. The addition of flavoring agent and sweetener plays a role in attracting food and suppressing bitterness, improving palatability. The use of co-solvent enables enrofloxacin to dissolve in water, which is convenient for poultry and non-eating animals to drink water.

本发明通过饮水或者内服(投服、拌料)给药,使用方便,使用效果好,香味剂和甜味剂的应用对家畜的适口性有显著改善。The present invention is administered through drinking water or oral administration (administration, mixing materials), is convenient to use, has good use effect, and the application of flavoring agent and sweetener can significantly improve the palatability of livestock.

具体实施方式detailed description

下面结合实施例与具体实施方式对本发明作进一步详细说明:Below in conjunction with embodiment and specific implementation mode, the present invention is described in further detail:

实施例1Example 1

由以下组分制备构成:恩诺沙星2.5-10克,美洛昔康0.05-1.0克,助溶剂2.5-10克,稳定剂0.5-4克,甜味剂1-2克,香味剂1-2克,辅料92-72克。It is prepared from the following components: 2.5-10 grams of enrofloxacin, 0.05-1.0 grams of meloxicam, 2.5-10 grams of co-solvent, 0.5-4 grams of stabilizer, 1-2 grams of sweetener, and 1 fragrance agent -2 grams, accessories 92-72 grams.

实施例2Example 2

美洛昔康与恩诺沙星重量比为0.2-1.0∶10,所述的美洛昔康除采用美洛昔康本身外,还可采用美洛昔康固体分散体或美洛昔康碱性盐。The weight ratio of meloxicam to enrofloxacin is 0.2-1.0:10, and the described meloxicam can also use meloxicam solid dispersion or meloxicam base in addition to meloxicam itself sexual salt.

实施例3Example 3

所述的美洛昔康固体分散体是指美洛昔康用熔融共溶法制备的美洛昔康PEG6000固体分散体,所述的美洛昔康碱性盐为葡甲胺盐或钠盐或钾盐或铵盐。Described meloxicam solid dispersion refers to the meloxicam PEG6000 solid dispersion that meloxicam prepares by melting co-dissolution method, and described meloxicam basic salt is meglumine salt or sodium salt Or potassium or ammonium salt.

实施例4Example 4

所述的助溶剂采用碳酸钠或碳酸钾。Described cosolvent adopts sodium carbonate or potassium carbonate.

实施例5Example 5

所述的稳定剂是选自EDTA2钠、依地酸钙钠、三聚磷酸钠、N-(2-羟乙基)-乙二胺三乙酸钠、N-(2-羟乙基)-甘氨酸,其中一种或几种的组合。The stabilizer is selected from sodium EDTA2, calcium sodium edetate, sodium tripolyphosphate, N-(2-hydroxyethyl)-sodium ethylenediaminetriacetate, N-(2-hydroxyethyl)-glycine , one or a combination of several of them.

实施例6Example 6

所述的甜味剂是选自,甜菊糖、山梨糖醇、甘露糖醇、麦芽糖醇、木糖醇糖精、甜蜜素、阿斯巴甜和安赛蜜,其中一种或几种的组合。The sweetener is selected from stevioside, sorbitol, mannitol, maltitol, xylitol saccharin, cyclamate, aspartame and acesulfame potassium, one or a combination thereof.

实施例7Example 7

所述的香味剂是选自:乙基香兰素、天然香料提取物、乙基麦芽酚、乙酸异戊酯、丁酸乙酯,其中一种或几种的组合。The flavoring agent is selected from: ethyl vanillin, natural fragrance extract, ethyl maltol, isoamyl acetate, ethyl butyrate, one or a combination thereof.

实施例8Example 8

所述的辅料是选自:葡萄糖、乳糖、蔗糖、水溶性淀粉、无水硫酸钠、碳酸氢钠,其中一种或几种的组合。The auxiliary material is selected from: glucose, lactose, sucrose, water-soluble starch, anhydrous sodium sulfate, sodium bicarbonate, one or more combinations thereof.

实施例9Example 9

制备方法如下:第一步,将美洛昔康与助溶剂逐级递增混合搅拌均匀,得到混合物A,再把制得的混合物A加到恩诺沙星中,得到混合物B,备用;The preparation method is as follows: in the first step, meloxicam and the co-solvent are gradually mixed and stirred uniformly to obtain a mixture A, and then the prepared mixture A is added to enrofloxacin to obtain a mixture B, which is set aside;

第二步,将稳定剂、甜味剂、香味剂混合搅拌均匀得到混合物C,再把制得的混合物C加到辅料中搅拌混合均匀,制得混合物D,最后将制得的混合物B与混合物D在室温下搅拌均匀,制得混合物E,备用;In the second step, mix and stir the stabilizer, sweetener, and flavoring agent to obtain mixture C, then add the prepared mixture C to the auxiliary materials and stir and mix evenly to obtain mixture D, and finally mix the prepared mixture B with the mixture D is stirred evenly at room temperature to obtain mixture E, which is set aside;

第三步,将制得的混合物E直接过筛或先粉碎后再过筛,筛网采用60~80目筛,按50g~1000g分装于包装袋或包装瓶中,封口或压盖后制得成品。The third step is to directly sieve the prepared mixture E or first crush it and then sieve it. The sieve uses a 60-80 mesh sieve, and packs it into a packaging bag or a packaging bottle according to 50g-1000g, and seals or presses the cap. Get the finished product.

Claims (9)

1.一种畜禽复方恩诺沙星美洛昔康可溶性粉,其特征在于:由以下组分制备构成:恩诺沙星2.5-10克,美洛昔康0.05-1.0克,助溶剂2.5-10克,稳定剂0.5-4克,甜味剂1-2克,香味剂1-2克,辅料92-72克。1. A livestock and poultry compound enrofloxacin-meloxicam soluble powder is characterized in that: it is prepared from the following components: 2.5-10 grams of enrofloxacin, 0.05-1.0 grams of meloxicam, and 2.5 grams of cosolvent -10 grams, 0.5-4 grams of stabilizer, 1-2 grams of sweetener, 1-2 grams of fragrance, 92-72 grams of auxiliary materials. 2.根据权利要求1所述的一种畜禽复方恩诺沙星美洛昔康可溶性粉,其特征在于:美洛昔康与恩诺沙星重量比为0.2-1.0∶10,所述的美洛昔康除采用美洛昔康本身外,还可采用美洛昔康固体分散体或美洛昔康碱性盐。2. A kind of livestock and poultry compound enrofloxacin meloxicam soluble powder according to claim 1, characterized in that: the weight ratio of meloxicam to enrofloxacin is 0.2-1.0: 10, and the In addition to meloxicam itself, meloxicam solid dispersion or basic salt of meloxicam can also be used. 3.根据权利要求2所述的一种畜禽复方恩诺沙星美洛昔康可溶性粉,其特征在于:所述的美洛昔康固体分散体是指美洛昔康用熔融共溶法制备的美洛昔康PEG6000固体分散体,所述的美洛昔康碱性盐为葡甲胺盐或钠盐或钾盐或铵盐。3. a kind of livestock and poultry compound enrofloxacin meloxicam soluble powder according to claim 2, is characterized in that: described meloxicam solid dispersion means that meloxicam is melted co-dissolving method The prepared meloxicam PEG6000 solid dispersion, the basic salt of meloxicam is meglumine salt or sodium salt or potassium salt or ammonium salt. 4.根据权利要求1所述的一种畜禽复方恩诺沙星美洛昔康可溶性粉,其特征在于:所述的助溶剂采用碳酸钠或碳酸钾。4. A livestock and poultry compound enrofloxacin-meloxicam soluble powder according to claim 1, characterized in that sodium carbonate or potassium carbonate is used as the co-solvent. 5.根据权利要求1所述的一种畜禽复方恩诺沙星美洛昔康可溶性粉,其特征在于:所述的稳定剂是选自EDTA2钠、依地酸钙钠、三聚磷酸钠、N-(2-羟乙基)-乙二胺三乙酸钠、N-(2-羟乙基)-甘氨酸,其中一种或几种的组合。5. a kind of livestock and poultry compound enrofloxacin meloxicam soluble powder according to claim 1, is characterized in that: described stabilizing agent is selected from EDTA2 sodium, edetate calcium sodium, sodium tripolyphosphate , N-(2-hydroxyethyl)-sodium ethylenediaminetriacetate, N-(2-hydroxyethyl)-glycine, one or a combination of them. 6.根据权利要求1所述的一种畜禽复方恩诺沙星美洛昔康可溶性粉,其特征在于:所述的甜味剂是选自,甜菊糖、山梨糖醇、甘露糖醇、麦芽糖醇、木糖醇糖精、甜蜜素、阿斯巴甜和安赛蜜,其中一种或几种的组合。6. a kind of livestock and poultry compound enrofloxacin meloxicam soluble powder according to claim 1, is characterized in that: described sweetener is selected from, stevioside, sorbitol, mannitol, Maltitol, xylitol saccharin, cyclamate, aspartame and acesulfame potassium, one or a combination of several. 7.根据权利要求1所述的一种畜禽复方恩诺沙星美洛昔康可溶性粉,其特征在于:所述的香味剂是选自:乙基香兰素、天然香料提取物、乙基麦芽酚、乙酸异戊酯、丁酸乙酯,其中一种或几种的组合。7. a kind of livestock and poultry compound enrofloxacin meloxicam soluble powder according to claim 1, is characterized in that: described fragrance agent is selected from: ethyl vanillin, natural flavor extract, ethyl vanillin Maltol, isoamyl acetate, ethyl butyrate, one or a combination of several of them. 8.根据权利要求1所述的一种畜禽复方恩诺沙星美洛昔康可溶性粉,其特征在于:所述的辅料是选自:葡萄糖、乳糖、蔗糖、水溶性淀粉、无水硫酸钠、碳酸氢钠,其中一种或几种的组合。8. A kind of livestock and poultry compound enrofloxacin meloxicam soluble powder according to claim 1, characterized in that: the auxiliary material is selected from: glucose, lactose, sucrose, water-soluble starch, anhydrous sulfuric acid Sodium, sodium bicarbonate, one or a combination of several. 9.一种畜禽复方恩诺沙星美洛昔康可溶性粉,其特征在于:制备方法如下:9. A livestock and poultry compound enrofloxacin meloxicam soluble powder, characterized in that: the preparation method is as follows: 第一步,将美洛昔康与助溶剂逐级递增混合搅拌均匀,得到混合物A,再把制得的混合物A加到恩诺沙星中,得到混合物B,备用;In the first step, meloxicam and co-solvent are gradually mixed and stirred uniformly to obtain mixture A, and then the prepared mixture A is added to enrofloxacin to obtain mixture B, which is set aside; 第二步,将稳定剂、甜味剂、香味剂混合搅拌均匀得到混合物C,再把制得的混合物C加到辅料中搅拌混合均匀,制得混合物D,最后将制得的混合物B与混合物D在室温下搅拌均匀,制得混合物E,备用;In the second step, mix and stir the stabilizer, sweetener, and flavoring agent to obtain mixture C, then add the prepared mixture C to the auxiliary materials and stir and mix evenly to obtain mixture D, and finally mix the prepared mixture B with the mixture D is stirred evenly at room temperature to obtain mixture E, which is set aside; 第三步,将制得的混合物E直接过筛或先粉碎后再过筛,筛网采用60~80目筛,按50g~1000g分装于包装袋或包装瓶中,封口或压盖后制得成品。The third step is to directly sieve the prepared mixture E or first crush it and then sieve it. The sieve uses a 60-80 mesh sieve, and packs it into a packaging bag or a packaging bottle according to 50g-1000g, and seals or presses the cap. Get the finished product.
CN201510658306.0A 2015-09-30 2015-09-30 A kind of livestock and poultry compound enrofloxacin Meloxicam soluble powder Active CN105213402B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510658306.0A CN105213402B (en) 2015-09-30 2015-09-30 A kind of livestock and poultry compound enrofloxacin Meloxicam soluble powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510658306.0A CN105213402B (en) 2015-09-30 2015-09-30 A kind of livestock and poultry compound enrofloxacin Meloxicam soluble powder

Publications (2)

Publication Number Publication Date
CN105213402A true CN105213402A (en) 2016-01-06
CN105213402B CN105213402B (en) 2018-12-18

Family

ID=54982919

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510658306.0A Active CN105213402B (en) 2015-09-30 2015-09-30 A kind of livestock and poultry compound enrofloxacin Meloxicam soluble powder

Country Status (1)

Country Link
CN (1) CN105213402B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105998036A (en) * 2016-05-19 2016-10-12 洛阳市兽药厂 Compound sulfa-nitazoxanide soluble powder for pigs and poultry
CN110327348A (en) * 2019-07-19 2019-10-15 余祖功 Compound long-acting injection and preparation method thereof containing Enrofloxacin and Meloxicam
CN115998674A (en) * 2021-10-22 2023-04-25 洛阳瑞华动物保健品有限公司 A kind of preparation method of enrofloxacin solution
CN116172960A (en) * 2022-12-01 2023-05-30 浙江大飞龙动物保健品股份有限公司 A kind of ciprofloxacin lactate soluble powder and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1273092A (en) * 2000-04-04 2000-11-15 华南农业大学 Water-soluble powdered quinolone medicines
CN1437472A (en) * 2000-06-20 2003-08-20 贝林格尔·英格海姆维特梅迪卡有限公司 Highly concentrated stable meloxicam solutions
CN101954084A (en) * 2010-09-06 2011-01-26 北京大北农动物保健科技有限责任公司 Medicinal composition for treating mixed infection in livestock and poultry and preparation method thereof
CN102038643A (en) * 2010-12-10 2011-05-04 青岛康地恩药业有限公司 Enrofloxacin soluble powder and preparation method and application thereof
CN102397552A (en) * 2010-09-10 2012-04-04 广州自远生物科技有限公司 Medicinal composite preparation containing quinolones and preparation method and application thereof
CN104367553A (en) * 2014-11-26 2015-02-25 上海同仁药业有限公司 Enrofloxacin soluble powder and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1273092A (en) * 2000-04-04 2000-11-15 华南农业大学 Water-soluble powdered quinolone medicines
CN1437472A (en) * 2000-06-20 2003-08-20 贝林格尔·英格海姆维特梅迪卡有限公司 Highly concentrated stable meloxicam solutions
CN101954084A (en) * 2010-09-06 2011-01-26 北京大北农动物保健科技有限责任公司 Medicinal composition for treating mixed infection in livestock and poultry and preparation method thereof
CN102397552A (en) * 2010-09-10 2012-04-04 广州自远生物科技有限公司 Medicinal composite preparation containing quinolones and preparation method and application thereof
CN102038643A (en) * 2010-12-10 2011-05-04 青岛康地恩药业有限公司 Enrofloxacin soluble powder and preparation method and application thereof
CN104367553A (en) * 2014-11-26 2015-02-25 上海同仁药业有限公司 Enrofloxacin soluble powder and preparation method thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105998036A (en) * 2016-05-19 2016-10-12 洛阳市兽药厂 Compound sulfa-nitazoxanide soluble powder for pigs and poultry
CN105998036B (en) * 2016-05-19 2018-07-27 洛阳市兽药厂 One boar fowl compound sulfonamide Nitazoxanide soluble powder
CN110327348A (en) * 2019-07-19 2019-10-15 余祖功 Compound long-acting injection and preparation method thereof containing Enrofloxacin and Meloxicam
CN115998674A (en) * 2021-10-22 2023-04-25 洛阳瑞华动物保健品有限公司 A kind of preparation method of enrofloxacin solution
CN116172960A (en) * 2022-12-01 2023-05-30 浙江大飞龙动物保健品股份有限公司 A kind of ciprofloxacin lactate soluble powder and preparation method thereof

Also Published As

Publication number Publication date
CN105213402B (en) 2018-12-18

Similar Documents

Publication Publication Date Title
JP5193308B2 (en) Rapid release liquid formulations, preparations and uses thereof
AU650706B2 (en) Medicaments
US7078053B2 (en) Ibuprofen composition
CN1681482B (en) Veterinary preparations not containing animal products
JP6273589B2 (en) Stabilized calisbamate pediatric suspension
US8545879B2 (en) Fast disintegrating compositions of meloxicam
CN101600418A (en) Effervescent formulations of florfenicol for addition to drinking water systems
CN100551378C (en) Aqueous formulations containing aminoglycoside antibiotics and bromfenac
JP2002537070A (en) Bioadhesive antimicrobial wound healing composition
JP2006505574A5 (en)
JP2001527567A (en) How to make flurbiprofen lozenges
NZ533092A (en) Coated particulate cefuroxime axetil compositions
CN105213402A (en) A kind of poultry compound enrofloxacin meloxicam soluble powder
BRPI0713933A2 (en) antihistamine syrups stable to sugar free storage
CN102458363A (en) Telmisartan drug oral solution
CN104983686A (en) Meloxicam soluble powder for livestock and poultry and preparation method thereof
US20070265344A1 (en) Non-steroidal anti-inflammatory oral powder and liquid preparations for administration to animals
WO2015117987A1 (en) Effervescent formulations comprising ibuprofen and n-acetylcystein
JPH06503826A (en) pharmaceutical composition
JP6995479B2 (en) Antimicrobial composition containing foaming agent
CN104352461A (en) Oral pharmaceutical preparation of tadalafil
TW200904401A (en) Combinations comprising pregabalin
US20060147481A1 (en) Ketoprofen powder for oral use
CN104274417A (en) Oral drug preparation of tadalafil
TR201620498A2 (en) PHARMACEUTICAL COMPOSITION CONTAINING ACETYLSISTE AND PARACETAMOL

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address

Address after: No. 6 Fuzuo Road, Shouyangshan Street, Yanshi District, Luoyang City, Henan Province, 471000

Patentee after: Luoyang Luoshen Pharmaceutical Co.,Ltd.

Country or region after: China

Address before: No. 11 Chezhan Road, Yanshi City, Henan Province 471000

Patentee before: LUOYANG VETERINARY MEDICINES FACTORY

Country or region before: China

CP03 Change of name, title or address